ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,820Medicare Part D Prescriptions Filled, Including Refills

Rank: 21 out of 1454

$1.39M Total Retail Price of All Prescriptions

Rank: 29 out of 1454

672 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 672 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

15% of this provider’s 672 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 23,645 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
FUROSEMIDE 1,004 902 1 6
LISINOPRIL 903 815 2 4
SIMVASTATIN 841 761 3 1
OMEPRAZOLE 829 716 4 3
LEVOTHYROXINE SODIUM 826 755 5 5
SERTRALINE HCL 739 675 6 26
AMLODIPINE BESYLATE 591 550 7 2
WARFARIN SODIUM 574 530 8 17
COUMADIN 555 519 9 119
DONEPEZIL HCL 517 510 10 29
HYDROCODONE-ACETAMINOPHEN 511 405 S3 11 7
POTASSIUM CHLORIDE 507 485 12 15
METOPROLOL TARTRATE 469 454 13 10
METFORMIN HCL 449 414 14 8
GABAPENTIN 406 363 15 16
METOPROLOL SUCCINATE 383 353 16 13
MIRTAZAPINE 381 377 17 53
MELOXICAM 360 341 18 37
NAMENDA 360 347 18 48
POLYETHYLENE GLYCOL 3350 337 334 20 61
TAMSULOSIN HCL 318 305 21 34
LOSARTAN POTASSIUM 309 290 22 14
ATENOLOL 309 266 22 18
DIVALPROEX SODIUM 304 281 24 106
ZOLPIDEM TARTRATE 300 235 25 19
CITALOPRAM HBR 274 265 26 21
HYDROCHLOROTHIAZIDE 235 207 27 9
ATORVASTATIN CALCIUM 228 202 28 11
RAMIPRIL 218 199 29 66
CARVEDILOL 216 193 30 24
METOCLOPRAMIDE HCL 215 179 31 121
GLIMEPIRIDE 213 190 32 33
CYMBALTA 209 160 33 55
FENTANYL 205 182 S2 34 104
CLOTRIMAZOLE-BETAMETHASONE 193 158 35 166
LANTUS 190 115 36 51
CLOPIDOGREL 188 174 37 32
DIGOXIN 185 169 38 70
PLAVIX 176 157 39 45
IPRATROPIUM-ALBUTEROL 162 133 40 151
PREDNISONE 160 126 41 36
RISPERIDONE 159 136 42 86
ALENDRONATE SODIUM 159 146 42 35
ALLOPURINOL 159 143 42 28
KLOR-CON M10 152 137 45 145
DILTIAZEM 24HR CD 146 146 46 76
CIPROFLOXACIN HCL 140 129 47 64
TRAZODONE HCL 138 113 48 50
ESCITALOPRAM OXALATE 132 116 49 78
QUETIAPINE FUMARATE 132 127 49 91
LEVETIRACETAM 131 98 51 114
NEXIUM 127 88 52 23
ISOSORBIDE MONONITRATE ER 126 120 53 46
LEVOXYL 116 83 54 84
ADVAIR DISKUS 113 84 55 47
TRAMADOL HCL 109 102 56 20
LABETALOL HCL 107 106 57 147
AZITHROMYCIN 107 93 57 42
CARBIDOPA-LEVODOPA 106 106 59 130
RANITIDINE HCL 106 86 59 43
DOXYCYCLINE HYCLATE 106 100 59 110
SPIRIVA 105 86 62 52
CRESTOR 104 98 63 22
ENALAPRIL MALEATE 104 90 63 58
KLOR-CON M20 103 89 65 54
PROMETHAZINE HCL 101 91 R 66 82
LISINOPRIL-HYDROCHLOROTHIAZIDE 98 96 67 27
FLUTICASONE PROPIONATE 96 87 68 30
PANTOPRAZOLE SODIUM 96 95 68 31
BACLOFEN 96 29 68 146
JANUVIA 89 75 71 77
AGGRENOX 87 73 72 161
OXYBUTYNIN CHLORIDE ER 86 86 73 156
PRAVASTATIN SODIUM 85 84 74 12
TRAVATAN Z 82 81 75 218
NOVOLOG 79 70 76 99
SANTYL 79 74 76 228
FINASTERIDE 78 78 78 94
LEVOFLOXACIN 77 70 79 95
LYRICA 77 43 79 103
TRIAMTERENE-HCTZ 75 66 81 44
FLUOXETINE HCL 73 43 82 72
FAMOTIDINE 70 70 83 88
LOVASTATIN 70 44 83 39
CLONIDINE HCL 67 67 85 49
AMIODARONE HCL 67 67 85 223
INSULIN SYRINGE 67 59 85 97
VERAPAMIL ER 65 65 88 89
METOLAZONE 63 63 89 216
DIOVAN 63 63 89 40
HYDRALAZINE HCL 62 55 91 67
OXYCODONE HCL 62 62 S2 91 80
DIVALPROEX SODIUM ER 62 51 91 222
CELEBREX 61 57 94 81
SEROQUEL 59 53 95 177
NAPROXEN 59 43 95 122
VALPROIC ACID 57 56 97 314
ACTOS 57 48 97 90
SINGULAIR 57 48 97 83
OLANZAPINE 57 55 97 163
VESICARE 56 56 101 199
AMITRIPTYLINE HCL 55 31 R 102 71
LOSARTAN-HYDROCHLOROTHIAZIDE 54 41 103 38
BENAZEPRIL HCL 54 54 103 57
NITROFURANTOIN MONO-MACRO 54 48 103 217
NIFEDIPINE ER 52 44 106 102
LEXAPRO 52 47 106 205
CYCLOBENZAPRINE HCL 52 0 R 106 59
ABILIFY 51 47 109 175
GLIPIZIDE 51 48 109 62
OXYCONTIN 50 32 S2 111 173
OXYBUTYNIN CHLORIDE 50 50 111 169
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.